2008. Natalizumab (Tysabri) in multiple sclerosis patients. Farmeconomia. Health Economics and Therapeutic Pathways. 9, 2 (Jun. 2008), 109–114. DOI:https://doi.org/10.7175/fe.v9i2.222.